Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Adrenocortical Carcinoma × Sunitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 86 Kidney Neoplasms 25 Neoplasms 24 Breast Neoplasms 18 Gastrointestinal Stromal Tumors 17 Neoplasm Metastasis 15 Carcinoma, Non-Small-Cell Lung 15 Prostatic Neoplasms 8 Urinary Bladder Neoplasms 7 Brain Neoplasms 7 Pancreatic Neoplasms 6 Lung Neoplasms 6 Colorectal Neoplasms 6 Thyroid Neoplasms 5 Stomach Neoplasms 5 Solid Tumors 5 Small Cell Lung Carcinoma 5 Ovarian Neoplasms 5 Neuroendocrine Tumors 5 Melanoma 5 Glioblastoma 5 Carcinoma 5 Sarcoma 4 Liver Neoplasms 4 Esophageal Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Carcinoma, Hepatocellular 4 Astrocytoma 4 Adenoma, Islet Cell 4 Thyroid Cancer, Papillary 3

Interventions

Cisplatin 7 Mitotane 5 Doxorubicin 5 Etoposide 4 relacorilant 2 Trastuzumab 2 Cytoreduction Surgical Procedures 2 tipifarnib 1 sodium thiosulfate 1 pembrolizumab 1 pegfilgrastim 1 iodophenyl metomidate 1 gossypol acetic acid 1 entinostat 1 cixutumumab 1 avelumab 1 Vincristine 1 Tamoxifen 1 TKM-080301 1 Suramin 1 Sunitinib 1 Streptozocin 1 Radiotherapy 1 Platinum 1 Oxaliplatin 1 Observation 1 N-Ac-CHAVC-NH2 1 N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride 1 Microscopy, Electron 1 Interleukin-12 Subunit p35 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00453895 2019-01-31

SIRAC

University of Wuerzburg

Phase 2 Completed

39 enrolled 10 charts

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡